<p>Ibogaine is a psychedelic alkaloid which has
been subject of intense scientific research due to its reported ability to
attenuate drug-seeking behavior. Recent work suggested that ibogaine effects on
alcohol self-administration in rats was related to the release of Glial Cell
Derived Neurotrophic Factor (GDNF) in the Ventral Tegmental Area (VTA), a
mesencephalic region which hosts soma of dopamine neurons. It is well known
that neurotrophic factors (NFs) mediate the neuroadaptations induced in the
mesocorticolimbic dopaminergic system by repeated exposure to drugs. Although
previous reports have shown ibogaine´s ability to induce GDNF expression in rat
midbrain, there are no studies addressing its effect on the expression of GDNF,
Brain Derived Neurotrophic Factor (BDNF) or Nerve Growth Factor (NGF) in
distinct regions containing dopaminergic neurons. In this work, we examined the
effect of ibogaine acute administration on the expression of these NFs in the VTA,
Prefrontal Cortex (PFC), Nucleus Accumbens (NAcc) and the Substantia Nigra
(SN). Thus, rats were i.p. treated with ibogaine 20 mg/kg (I<sub>20</sub>), 40
mg/kg (I<sub>40</sub>) or vehicle, and NFs expression was analyzed after 3 and
24 hours. Only at 24 h an increase of the expression for the three NFs were
observed in a site and dose dependent manner. Results for GDNF showed that only
I<sub>40</sub> selectively upregulated its expression in the VTA and SN. Both
doses of ibogaine elicited a large increase in the expression of BDNF in the
NAcc, SN and PFC, while a significant effect was found in the VTA only for I<sub>40</sub>.
Finally, NGF was found to be upregulated in all regions after I<sub>40</sub>,
while a selective upregulation was found in PFC and VTA for the I<sub>20</sub>
treatment. An increase in the content of mature GDNF was observed in the VTA
but no significant increase in the mature BDNF protein content was found in all
the studied areas. Interestingly, an increase in the content of proBDNF was
detected in the NAcc for both treatments. Further research is needed to
understand the neurochemical bases of these changes, and to confirm their
contribution to the anti-addictive properties of ibogaine. </p>